Objective To explore the clinical application value of hybrid operation platform in treatment of patients with placenta previa and placenta accreta.Methods A retrospective analysis on 60 severe cases with placenta previa and placenta accreta in the hospital from June 2012 to December 2015 was performed.According to different treatment methods,these cases were divided into observation group and control group.A total of 18 cases treated by cesarean section combined with uterine artery embolization were selected as observation group,and 42 cases treated by termination of pregnancy by traditional cesarean section were selected as control group.The operation time,intraoperative bleeding volumes,the volumes of intraoperative and postoperative blood transfusion,hysterectomy rates,postoperative hospitalization time,neonatal Apgar scores,incidence rates of shock and disseminated inravascular coagulation (DIC) were compared between the two groups.Results The intraoperative bleeding volume,the volumes of intraoperative and postoperative blood transfusion,hospitalization time,hysterectomy rate,and incidence rate of shock in observation group were significantly lower than those in control group (P＜0.05).There was no statistically significant difference in operation time,neonatal Apgar score,and the incidence rate of DIC between the two groups (P＞0.05).Conclusion Compared with conventional cesarean section,cesarean section combined with uterine artery embolization in hybrid operation room can avoid unnecessary transportation of patients with placenta previa and placenta accreta.It is a safe and effectivemethod to reduce the volume of intraoperative bleeding and the incidence rate of hysterectomy.
目的：探讨通过饮食指导、运动对妊娠期糖尿病孕妇血糖进行控制，对新生儿出生体重的影响。方法回顾性分析收治的59例妊娠期糖尿病患者的临床资料，其中血糖控制满意的26例作为观察组，血糖控制不满意的33例作为对照组，比较分析两组孕妇分娩的新生儿体重。结果血糖控制满意组其巨大儿的发生率明显低于血糖控制不满意组，两组比较差异有统计学意义（P＜0.05）。结论饮食及运动疗法，可以有效控制患者血糖在正常水平，减少巨大儿的出生率及由巨大儿带来的母婴并发症的发生率。
Objective:To stuby the changes of blood lipoprotein,leptin,and sex hormone in post-menopausal women with hyper.lipohemia treated by oral Niletrioli.Methods:46 post-menopausal women with hyper-lipohemia were treated with oral 2mg Niletrioli once every other week and 2mg medroxyprogesterone acetate(MPA) once every other day.Serum cholesterol,leptin,and sex hormone were measured after 3 month and 6 month of treatment,and serum cholesterol was monitored lasting to 36 months after trestment.Results:Compared to pre-treatment,high-density lipoproteins-cholesterol(HDL-C)increased,low-density lipoprotein-cholesterol(LDL-C) and total cholesterol(TC) decreased after 3 and 6 months of treatment,but there was no significant difference;Serum leptin,body weight,and BMI weakly decreased and no remarkably difference;Serum FSH and LH decreased significantly(P0.01).Serum HDL-C,LDL-C,and TC levels kept stable after 18-36 months of treatment,and serum TG almost had on changes during treatment and follow-up.Conclusions:Niletrioli is benefit for blood lipoprotein in postme nopausal women with hyper-lipohemia.
